New breathing program aims to ease breathlessness in advanced lung cancer
NCT ID NCT06791057
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a short behavioral program called BREEZE+ to help people with advanced lung cancer manage breathlessness. The program includes three nurse-led sessions and a digital app that teaches breathing and relaxation skills. Researchers will compare this to usual care in 420 participants to see if it reduces breathlessness and related anxiety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
brief behavioral intervention (BREEZE+) including nurse-led sessions and a digital health app
What this could lead to
If it works, this could provide a practical, non-drug way to help people with advanced lung cancer feel less breathless and more in control.
What could go wrong
This is a relatively early-stage trial testing a behavioral approach, so the effect may be small or not work for everyone. The intervention requires patient engagement, which may be challenging.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Miami
Coral Gables, Florida, 33124, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact